The Journal of Immunology, Vol 159, Issue 4 1619-1627, Copyright © 1997 by American Association of Immunologists

ARTICLES

Modulation of lymphocyte interaction with endothelium and homing by HIV- 1 gp120

M Bragardo, D Buonfiglio, MJ Feito, S Bonissoni, V Redoglia, JM Rojo, S Ballester, P Portoles, G Garbarino, F Malavasi and U Dianzani
Dipartimento di Scienze Mediche, Universita di Torino at Novara, Italy.

We have previously shown that HIV-1 glycoprotein 120 (gp120) induces CD4 association with several molecules on the surface of CD4+ lymphocytes. Since one of these molecules was CD38, involved in lymphocyte/endothelium interaction, this article examines the possibility that gp120/CD4 binding alters CD4+ T cell interaction with vascular endothelium in vitro and in vivo. Cocapping experiments showed that gp120 induced CD4 association with CD38, CD29, CD49d, and CD11a in peripheral blood CD4+ T cells. Two in vitro binding assays were used to evaluate the effect of gp120. A static binding assay, performed at 37 degrees C, evaluated stable interactions mediated by integrins, and a dynamic binding assay, performed at 4 degrees C on a rocking shelf, evaluated weak interactions mediated by constitutively active molecules such as selectins and CD38. Gp120 increased dynamic binding and inhibited static binding to the endothelium of peripheral blood CD4+ T cells and SUPT-1 cells. Binding inhibition with mAbs suggested that the gp120 effect on dynamic binding involved CD38, CD31, and CD49d, whereas the effect on static binding involved CD11a and CD49d. In vivo experiments showed that treatment of 2D4 cells, a CD4- CD8- mouse T cell clone transfected with the human CD4, with gp120 increased their homing into the spleen, intestine, and mesenteric lymph nodes, whereas it decreased homing into peripheral lymph nodes. Alteration of lymphocyte homing may contribute to immune deficiency in HIV-1+ patients by decreasing the probability of an encounter between Ags and lymphocytes and inhibiting the spread of effector lymphocytes into tissues.

This article has been cited by other articles:

				E. R. Kline, D. J. Kleinhenz, B. Liang, S. Dikalov, D. M. Guidot, C. M. Hart, D. P. Jones, and R. L. Sutliff Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2792 - H2804. [Abstract] [Full Text] [PDF]

				A. Bugatti, C. Urbinati, C. Ravelli, E. De Clercq, S. Liekens, and M. Rusnati Heparin-Mimicking Sulfonic Acid Polymers as Multitarget Inhibitors of Human Immunodeficiency Virus Type 1 Tat and gp120 Proteins Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2337 - 2345. [Abstract] [Full Text] [PDF]

				J. J-Y. Chen, J. C. Huang, M. Shirtliff, E. Briscoe, S. Ali, F. Cesani, D. Paar, and M. W. Cloyd CD4 lymphocytes in the blood of HIV+ individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion J. Leukoc. Biol., August 1, 2002; 72(2): 271 - 278. [Abstract] [Full Text] [PDF]

				K. Ikuta, S. Suzuki, H. Horikoshi, T. Mukai, and R. B. Luftig Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 725 - 745. [Abstract] [Full Text] [PDF]

				A. SAVARINO, F. BOTTAREL, L. CALOSSO, M. J. FEITO, T. BENSI, M. BRAGARDO, J. M. ROJO, A. PUGLIESE, I. ABBATE, M. R. CAPOBIANCHI, et al. Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle FASEB J, December 1, 1999; 13(15): 2265 - 2276. [Abstract] [Full Text]

				C. D. Katsetos, J. E. Fincke, A. Legido, H. W. Lischner, J.-P. de Chadarevian, E. M. Kaye, C. D. Platsoucas, and E. L. Oleszak Angiocentric CD3+ T-Cell Infiltrates in Human Immunodeficiency Virus Type 1-Associated Central Nervous System Disease in Children Clin. Vaccine Immunol., January 1, 1999; 6(1): 105 - 114. [Abstract] [Full Text] [PDF]